FDA lays out digital health goals in 2018 strategic roadmap

OCT - digital therapeutics
Leveraging innovation and competition to better healthcare is one of the four cornerstones of the Food and Drug Administration’s 2018 policy roadmap
“The roadmap touches on several efforts to help develop medical devices, specifically the establishment of a Total Product Life Cycle Office within the Center for Devices and Radiological Health and the development of an alternative 510(k) pathway. FDA also plans to publish final guidance on what digital health technologies fall under FDA’s regulation and those that the agency plans to exercise enforcement discretion on. In December, the agency published a trio of documents that laid out its proposed thoughts on how it will approach its regulation of the space. The FDA chief acknowledged that modernizing how the agency regulates new areas such as digital health to ensure that the agency’s policies are suited to the new challenges. The plan pointed to enabling consumers to use new technologies, such as digital tools and medical apps, to make up-to-date decisions about their health.” Read the full article.
Check out this article and more on social media!

Related Posts

Scaling Member Services to Meet Demand

Payers offering managed Medicaid and ACA plans operate in one of the most dynamic service environments in healthcare. Enrollment can ...

Modernizing Premium Billing for Medicaid and Public Program Plans

Premium billing for Medicaid and other public program plans has become increasingly complex. Shifting eligibility rules, fluctuating member responsibility amounts, ...

Our Most Viewed Blogs of 2025

In 2025 HealthAxis lead the conversations regarding the intersection of healthcare administration, technology, and compliance. Last year’s most popular blogs reflect a deep industry focus on operational efficiency, regulatory ...

Want To Know How We Can Help Your Organization?